Antibiotic-impregnated catheters associated with significant decrease in nosocomial and multidrug-resistant bacteremias in critically ill patients

被引:57
|
作者
Hanna, HA
Raad, II
Hackett, B
Wallace, SK
Price, KJ
Coyle, DE
Parmley, CL
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Unit 402, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Crit Care Med, Houston, TX 77030 USA
关键词
antibiotic-impregnated central venous catheter; central venous catheters; ICU; minocycline; nosocomial bloodstream infections; rifampin;
D O I
10.1378/chest.124.3.1030
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the impact of using central venous catheters (CVCs) impregnated with the combination of minocycline and rifampin on nosocomial bloodstream infections (BSIs), morbidity, and mortality in cancer patients in the ICU. Design: Prospective surveillance study consisting of the following two time periods: September 1997 through August 1998 (ie, fiscal year [FY] 1998); and from September 1998 through August 1999 (ie, FY 1999). Setting: ICUs of a tertiary care hospital in Houston, TX. Patients: Cancer patients in the medical ICU (MICU) and surgical ICU (SICU). Interventions: ICUs started using CVCs impregnated with the minocycline-rifampin combination at the beginning of FY 1999. Measurements and main results: The rates of nosocomial BSIs and other patients' characteristics were compared for the two study periods to determine the impact of using the impregnated catheters in the ICU. Patients' characteristics, including antibiotic use, were comparable for,the two study periods in both the MICU and the SICU. The rate of nosocomial BSIs in the MICU unit decreased from 8.3 to 3.5 per 1,000 patient-days (p < 0.01), and decreased in the SICU from 4.8 to 1.3 per 1,000 patient-days (p < 0.01) in FY 1999. Nosocomial vancomycin-resistant enterococcus (VRE) bacteremia also decreased significantly (p = 0.004). Length of stay in the MICU and SICU significantly decreased in FY 1999 (p < 0.01 and p = 0.03, respectively). The duration of hospitalization decreased for MICU and SICU patients (p = 0.06 and p < 0.01, respectively). The rate of catheter-related infections decreased from 3.1 to 0.7 per 1,000 patient-days in FY 1999 (p = 0.02). The decrease in infections resulted in net savings of at least $1,450,000 for FY 1999. Conclusions: The use of antibiotic-impregnated CVCs in the MICU and SICU was associated with a significant decrease in nosocomial BSIs, including VRE bacteremia, catheter-related infections, and lengths of hospital and ICU stays.
引用
收藏
页码:1030 / 1038
页数:9
相关论文
共 8 条
  • [1] Association Between Multidrug-Resistant Bacteria and Mortality in Critically Ill Patients
    Duclos, Gary
    Lakbar, Ines
    Boucekine, Mohamed
    Lolo, Georges
    Cassir, Nadim
    Leone, Marc
    ADVANCES IN THERAPY, 2023, 40 (04) : 1736 - 1749
  • [2] Hospital Costs Associated With Shunt Infections in Patients Receiving Antibiotic-Impregnated Shunt Catheters Versus Standard Shunt Catheters
    Attenello, Frank J.
    Garces-Ambrossi, Giannina L.
    Zaidi, Hasan A.
    Sciubba, Daniel M.
    Jallo, George I.
    NEUROSURGERY, 2010, 66 (02) : 284 - 289
  • [3] Intravenous Colistin for Multidrug-Resistant Gram-Negative Infections in Critically Ill Pediatric Patients
    Kapoor, Kapil
    Jajoo, Mamta
    Dublish, Swati
    Dabas, Vikas
    Gupta, Shalu
    Manchanda, Vikas
    PEDIATRIC CRITICAL CARE MEDICINE, 2013, 14 (06) : E268 - E272
  • [4] Multidrug-Resistant Infections and Outcome of Critically Ill Patients with Coronavirus Disease 2019: A Single Center Experience
    Karruli, Arta
    Boccia, Filomena
    Gagliardi, Massimo
    Patauner, Fabian
    Ursi, Maria Paola
    Sommese, Pino
    De Rosa, Rosanna
    Murino, Patrizia
    Ruocco, Giuseppe
    Corcione, Antonio
    Andini, Roberto
    Zampino, Rosa
    Durante-Mangoni, Emanuele
    MICROBIAL DRUG RESISTANCE, 2021, 27 (09) : 1167 - 1175
  • [5] Validating a prediction tool to determine the risk of nosocomial multidrug-resistant Gram-negative bacilli infection in critically ill patients: A retrospective case-control study
    Boyd, Sara E.
    Vasudevan, Anupama
    Moore, Luke S. P.
    Brewer, Christopher
    Gilchrist, Mark
    Costelloe, Ceire
    Gordon, Anthony C.
    Holmes, Alison H.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 826 - 831
  • [6] Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection
    Karballaei-Mirzahosseini, Hossein
    Kaveh-Ahangaran, Romina
    Shahrami, Bita
    Rouini, Mohammad Reza
    Najafi, Atabak
    Ahmadi, Arezoo
    Sadrai, Sima
    Mojtahedzadeh, Amirmahdi
    Najmeddin, Farhad
    Mojtahedzadeh, Mojtaba
    DARU-JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 30 (02) : 311 - 322
  • [7] Pharmacokinetic study of high-dose oral rifampicin in critically Ill patients with multidrug-resistant Acinetobacter baumannii infection
    Hossein Karballaei-Mirzahosseini
    Romina Kaveh-Ahangaran
    Bita Shahrami
    Mohammad Reza Rouini
    Atabak Najafi
    Arezoo Ahmadi
    Sima Sadrai
    Amirmahdi Mojtahedzadeh
    Farhad Najmeddin
    Mojtaba Mojtahedzadeh
    DARU Journal of Pharmaceutical Sciences, 2022, 30 : 311 - 322
  • [8] A two-year retrospective study of multidrug-resistant Acinetobacter baumannii respiratory infections in critically Ill patients: Clinical and microbiological findings
    Hafiz, Taghreed A.
    Alghamdi, Shahad S.
    Mubaraki, Murad A.
    Alghamdi, Shymaa S. M.
    Alothaybi, Abdulwahab
    Aldawood, Esraa
    Alotaibi, Fawziah
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2023, 16 (03) : 313 - 319